Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Feb 22, 2021 12:17pm
136 Views
Post# 32626863

RE:This is not new ..but an eye opener for SARB and the other

RE:This is not new ..but an eye opener for SARB and the other
I know this, I always keep my eyes open. So CBDT sold 1000 tests in a day, which means 30,000 a month. Keep in mind that is not their average, just one day. So with that market cap for CBDT as of today is over $650 million.
 
Medivolve sold about 73,973 tests in January. February probably is better with 30 extra testing sites. This means the Medivolve market cap should be higher with more than double the revenue. Instead, the market cap for Medivolve is $77 million. Go figure.
 
No worry, we will get our turn. Medivolve to achieve a $650 million market cap should be trading around $4. I am saying it for a long time and you are proving my point. If it is not for manipulation, Medivolve should be trading over $500 million market cap by now. 

knowsbest wrote: losers on this board .STOP THE PUMP 

https://www.empowerclinics.com/news/press/

CBDT 

Today more beach and meetings in between . Will let the machine do the Job 



<< Previous
Bullboard Posts
Next >>